Edwards Lifesciences has earned FDA clearance for its blood flow monitoring platform.
Johnson & Johnson has acquired 3D-printing technology from Tissue Regeneration Systems.
Verily launched Project Baseline, which aims to better understand what it means to be healthy and how health transitions to disease.
Theranos promised CMS it will not run a lab for two years and settled to pay up $4.65 million to Arizona residents who had taken Theranos blood tests.
Boston Scientific has led a $23.1 million Series B investment in in heart failure firm NeuroTronik.
Musculoskeletal cancer specialist Onkos Surgical raised $17.6 million in Series B funding, which will boost its sales, marketing and R&D ops.
Cardinal Health will acquire Medtronic’s Patient Care, Deep Vein Thrombosis and Nutritional Insufficiency units for $6.1 billion in cash.
Bristol-Myers Squibb and Denmark’s Nordic Bioscience inked a deal to develop biomarker technology to diagnose and monitor nonalcoholic steatohepatitis.
Verily has unveiled its long-discussed wearable health tracker, Study Watch.
Massachusetts biotech Sentien has filed for approval to start clinical trials of a blood filtering device packed with bone marrow cells for severe cases of…